Ancillary Testing in Neuro-ophthalmology : OCT et al./media/Images/Swedish/CME1/SyllabusPDFs... · neuro-ophthalmology and neurology –Demyelinating disease –Optic nerve edema

Post on 23-Mar-2020

2 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

Transcript

1

Ancillary Testing in Neuro-ophthalmology :

OCT et al.

Bonnie M. Keung, MD

Neuro-ophthalmology Clinic

2

Objectives

• Review of retinal and optic nerve anatomy

• To understand the role of OCT technology in neuro-ophthalmology and neurology

– Demyelinating disease

– Optic nerve edema vs pseudopapilledema

– Compression of the optic nerve

• Basic interpretation of OCT RNFL and GCC

3

OCT

• Ancillary test in neuro-ophthalmology clinic

• OCT is a quick, non-contact, non-contrast technique for imaging tissues at a 3D micron- level resolution

• O = Optical = Light (infrared light)

• C = Coherence = monochromatic light

• T = Tomography = slices

4

5

Resolution of OCT

http://obel.ee.uwa.edu.au/research/fundamentals/introduction-oct/

6

OCT

• There are four generations

– 3rd generation: Time domain

– 4th generation: Spectral domain

• Routinely used in ophthalmology

– Glaucoma

– Retinal pathology

7

Kimbrel EA, Lanza R. Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov. 2015 Oct;14(10):681-92

8

http://www.siumed.edu/~dking2/ssb/EE020b.htm

9

Duker JS, et al. Handbook of Retinal OCT. 2014

10

OCT: imaging the macula

Case

• 50 yo neurosurgeon presents with central vision loss OS x 2 weeks, metamorphopsia

• PMH: seasonal allergies

• Meds: intranasal steroid spray

11

12

OCT: imaging the macula

Case

• Exam

– VA 20/20, 20/60

– No RAPD

13

OCT: imaging the macula

14

OCT: imaging the macula

Duker JS, et al. Handbook of Retinal OCT. 2014

15

OCT: imaging the macula Central Serous Chorioretinopathy

(CSCR)

• Build up of sub-retinal fluid in macula

• Related to increased corticosteroid exposure, stress, type A personality

• Resolves spontaneously in a few months

16

OCT: macula to nerve

17

OCT: RNFL Retinal Nerve Fiber Layer

18

OCT: RNFL Retinal Nerve Fiber Layer

Lamirel C,et al. Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris). 2010 Dec;166(12):978-86.

19

OCT: print out

20

OCT: RNFL

21

OCT: GCC Ganglion Cell Complex

22

• 23 yo with right sided headache x 10 days, followed by 24 hours of progressive vision loss OD. Eye pain OD with movement.

• EXAM

– VA hand motion OD

– large RAPD OD

– Fundus exam: swelling of the optic nerve

CASE

23

CASE Goldmann Visual Field OD

24

Case Goldmann Visual Field OS

25

OCT RNFL

26

OCT GCC

27

OCT Macula

28

CASE

29

CASE – Optic neuritis Anterior and retrobulbar

• Received IV solumedrol: 1 g daily x 5 days

• 1 month follow up

– No pain

– VA 20/20 OD and 20/20 OS

• Was OCT really necessary?

30

OCT- Optic Neuritis with Disc swelling - Acute

31

OCT- Optic Neuritis with Disc swelling 1 month later…

32

OCT & Optic neuritis

• Loss of up to 20 microns per optic neuritis

• RNFL thinning occurs later

– 3-6 months

Costello F et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006 59:963-969

33

OCT & Optic Neuritis

• Optic neuritis

– RNFL 75 u = threshold value for visual recovery*

Costello F, et al. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler. 2008 Aug;14(7):893-905

34

OCT & Optic Neuritis

• Case of using GCL, in optic neuritis MS

• Not affected by swelling of the nerve

• Earlier loss

35

OCT and Multiple Sclerosis (MS) • OCT in non-ON eyes showed thinning in RNFL

compared to controls

• OCT predicts MS disability in patient without ON

– RNFL < 88 u

• 2x risk of disability worsening in 1-3 years

• 4x risk of disability worsening in 3-5 years

• OCT of GCC thinning reliably mirrors brain degeneration

– More strongly associated with progressive MS

Martinez-Lapiscina EH, et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016 May;15(6):574-84. Saidha, S., et al (2015), Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol., 78: 801–813

36

OCT and NMOSD

• Average RNFL loss after MS-ON= 20 u

• Average RNFL loss after NMO-ON = 55-83 u

• Fellow eye in NMO less affected

37

OCT? Papilledema vs Pseudopapilledema

CASE

• 20 yo female with history of migraine with aura, 3 months of worsened headache.

• Seen by optometry, referred urgently for papilledema with VA 20/20 OD and OS. Mother requesting that MRI be done right now.

38

OCT? Papilledema vs Pseudopapilledema

EXAM

VA: 20/20 OD and OS, no dyschromatopsia

Motility: full, orthophoric

39

OCT? Papilledema vs Pseudopapilledema

+HVF testing = normal

+OCT =

+CT scan (old) =

40

Optic Disc Drusen (ODD)

• Autosomally dominant inherited

• Intracellular and extracellular deposits that become calcified over time.

• Scalloped disc margins

41

Optic Disc Drusen (ODD)

• 0.3%-2% of population

• Usually asymptomatic, or some visual field defects

42

OCT? Papilledema vs Pseudopapilledema

43

44

Papilledema vs Pseudopapilledema Drusen

• ? OCT

• Fundus EXAM!

• B scan

• CT scan

• Fluorescein angiogram (FANG)

• Fundus auto-fluorescence (FAF)

• Lumbar puncture

• Enhanced depth OCT (EDI-OCT)

45

The Fundus EXAM

Papilledema

• Disc vessels are obscured

• Elevation goes beyond disc

• Hemorrhages, exudates

• Not familial

Pseudopapilledema

• Overt superficial drusen

• Disc vessels clear

• Elevation confined to disc

• Usually no hemorrhages

• Drusen- autosomal dominant

46

The Fundus EXAM

47

B-scan

48

CT scan

https://radiologykey.com/the-orbit/

49

Fluorescein Angiogram

50

Fundus Autofluorescence (FAF)

51

Enhanced depth OCT (EDI-OCT)

Silverman AL, Tatham AJ, Medeiros FA, Weinreb RN. Assessment of optic nerve head drusen using enhanced depth imaging and swept source optical coherence tomography. J Neuroophthalmol. 2014 Jun;34(2):198-205

52

OCT: Papilledema

CASE

• 23 yo obese female

• 2 weeks of headache, shoulder pain, double vision

• Mason General – CT (-), MRV (-), LP = 49 cm H20

– Acetazolamide 1500 mg daily

• Optometrist calls – VA 20/80 OD, 20/70 OS

53

OCT: Papilledema

54

OCT: Papilledema

EXAM

• 250#

• Esotropia

• Stage 4 disc swelling

https://clinicalgate.com/use-of-the-hand-held-ophthalmoscope/

55

Goldmann Visual Field OD

56

Goldmann Visual Field OS

57

OCT: Papilledema

DIAGNOSIS:

• IIH, visual dysfunction

58

IIH: Idiopathic Intracranial Hypertension

59

OCT: Papilledema

DIAGNOSIS:

• IIH, visual dysfunction

PLAN:

• Acetazolamide 3500 mg daily

• Weight loss

• Close follow up – Serial visual fields

– Serial OCTs

60

OCT: Papilledema

61

Follow-up Goldmann Visual Field

62

OCT: Pseudopapilledema vs Papilledema

• OCT can be used to aid in the differentiation between pseudopapilledema and papilledema

– Still lean on fundus exam, HPI

– Buried Drusen

• B scan, CT scan, FANG, FAF

• In cases of IIH, OCT can objectively track RNFL elevation and help explain progress to patient

63

OCT: Pituitary Adenoma

CASE • 56 y/o veteran with frontal and retro-orbital

headache, many weeks • First received anti-biotics for presumed sinusitis • Three days later, “blurred vision OS > OD”

• VA: 20/25 OD, 20/60 OS • Normal ophthalmologic examination

– Ophthalmology attending: “He did have a trace RAPD OS”

64

65

66

67

Junctional Scotoma

68

OCT: Pituitary Adenoma

• Significant improvement in visual field if baseline OCT

– RNFL was normal

– if > 75-80 microns

Danesh-Meyer HV, et al. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci. 2008 May;49(5):1879-85

69

top related